Acteoside

N/A

Report date: 2025/05/30 16:41:24

Base Information

Drug NameActeoside
Drug Alias NameverbascosidekusagininTJC-160NSC-603831
ClassificationNatural product/Extract
Mechanisms of ActionApoptosis inducersantioxidantHIV integrase inhibitors +[5] 
TargetsHIV integraseProtein kinase CXanthine dehydrogenase
Therapy Area/IndicationsNephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTSUMURA & CO
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTSUMURA & CO
Active IndicationsN/A
Inactive IndicationsNephritis

Other Information

ATC CodeN/A
Related LinksN/A